| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response
|
Loungani, Rahul S.
|
|
|
225 |
C |
p. 3-9
|
artikel
|
| 2 |
Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry
|
Lowenstern, Angela
|
|
|
225 |
C |
p. 88-96
|
artikel
|
| 3 |
Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study
|
Silvain, Johanne
|
|
|
225 |
C |
p. 27-37
|
artikel
|
| 4 |
Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: Insights from an international survey
|
Smilowitz, Nathaniel R.
|
|
|
225 |
C |
p. 55-59
|
artikel
|
| 5 |
COVID-19 pandemic—Some cardiovascular considerations from the trench
|
Cortese, Bernardo
|
|
|
225 |
C |
p. 1-2
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
225 |
C |
p. iv
|
artikel
|
| 7 |
Effect on thromboprophylaxis among hospitalized patients using a system-wide multifaceted quality improvement intervention: Rationale and design for a multicenter cluster randomized clinical trial in China
|
Dong, Fen
|
|
|
225 |
C |
p. 44-54
|
artikel
|
| 8 |
Epinephrine stress testing during cardiac catheterization in patients with aortic coarctation
|
Meijs, Timion A.
|
|
|
225 |
C |
p. 78-87
|
artikel
|
| 9 |
Evaluation of safety and efficacy of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: Design and rationale for the Disrupt CAD III trial
|
Kereiakes, Dean J.
|
|
|
225 |
C |
p. 10-18
|
artikel
|
| 10 |
Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants
|
Herkert, Johanna C.
|
|
|
225 |
C |
p. 108-119
|
artikel
|
| 11 |
Information for Readers
|
|
|
|
225 |
C |
p. v
|
artikel
|
| 12 |
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events
|
White, Harvey D.
|
|
|
225 |
C |
p. 97-107
|
artikel
|
| 13 |
Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission
|
Ae, Ryusuke
|
|
|
225 |
C |
p. 120-128
|
artikel
|
| 14 |
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial
|
Guedeney, Paul
|
|
|
225 |
C |
p. 60-68
|
artikel
|
| 15 |
Randomized trial of argatroban plus recombinant tissue-type plasminogen activator for acute ischemic stroke (ARAIS): Rationale and design
|
Yang, Yingying
|
|
|
225 |
C |
p. 38-43
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
225 |
C |
p. i-iii
|
artikel
|
| 17 |
Targeted temperature management in cardiac arrest patients with a non-shockable rhythm: A national perspective
|
Khan, Muhammad Zia
|
|
|
225 |
C |
p. 129-137
|
artikel
|
| 18 |
TAVR for low-flow, low-gradient aortic stenosis: Prognostic impact of aortic valve calcification
|
Ludwig, Sebastian
|
|
|
225 |
C |
p. 138-148
|
artikel
|
| 19 |
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
|
Karthikeyan, Ganesan
|
|
|
225 |
C |
p. 69-77
|
artikel
|
| 20 |
TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial
|
Laine, Marc
|
|
|
225 |
C |
p. 19-26
|
artikel
|
Tijdschrift beschrijving